FBX
ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
Created: | 2020-04-27 |
Last modified: | 2020-11-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 40 |
Chiral Atom Count | 0 |
Bond Count | 41 |
Aromatic Bond Count | 12 |
Chemical Component Summary | |
---|---|
Name | ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate |
Synonyms | Retigabine; Ezogabine |
Systematic Name (OpenEye OEToolkits) | ethyl ~{N}-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate |
Formula | C16 H18 F N3 O2 |
Molecular Weight | 303.331 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | CACTVS | 3.385 | CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N |
SMILES | OpenEye OEToolkits | 2.0.7 | CCOC(=O)Nc1ccc(cc1N)NCc2ccc(cc2)F |
Canonical SMILES | CACTVS | 3.385 | CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N |
Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CCOC(=O)Nc1ccc(cc1N)NCc2ccc(cc2)F |
InChI | InChI | 1.03 | InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21) |
InChIKey | InChI | 1.03 | PCOBBVZJEWWZFR-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB04953 |
---|---|
Name | Ezogabine |
Groups |
|
Description | Ezogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in adult patients with refractory epilepsy. FDA approved in June 10, 2011 under the name of ezogabine. |
Synonyms |
|
Brand Names |
|
Indication | Adjuvant treatment of partial-onset seizures. |
Categories |
|
ATC-Code | N03AX21 |
CAS number | 150812-12-7 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Potassium voltage-gated channel subfamily KQT member 3 | MGLKARRAAGAAGGGGDGGGGGGGAANPAGGDAAAAGDEERKVGLAPGDV... | unknown | modulator |
Potassium voltage-gated channel subfamily KQT member 2 | MVQKSRNGGVYPGPSGEKKLKVGFVGLDPGAPDSTRDGALLIAGSEAPKR... | unknown | |
Potassium voltage-gated channel subfamily KQT member 4 | MAEAPPRRLGLGPPPGDAPRAELVALTAVQSEQGEAGGGGSPRRLGLLGS... | unknown | |
Potassium voltage-gated channel subfamily KQT member 5 | MPRHHAGGEEGGAAGLWVKSGAAAAAAGGGRLGSGMKDVESGRGRVLLNS... | unknown | |
UDP-glucuronosyltransferase 1A1 | MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQL... | unknown | substrate |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL41355 |
PubChem | 121892 |
ChEMBL | CHEMBL41355 |
ChEBI | CHEBI:68584 |
CCDC/CSD | YETJUF01, YETKOA, YETKEQ, YETKAM |